Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 in active rheumatoid arthritis
NCT00383188Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Jul 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 12
01
Overview
Phase 2, randomised, double-blind trial of PH-797804 in rheumatoid arthritis (RA) (5 arms), sponsored by Pfizer. Primary endpoint: American College of Rheumatology 20% Response at 12 weeks. Started Dec 2006; status: completed.
02
Drugs
PH-797804
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00383188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383188.